Skip to main content
In honor of National Cancer Prevention Month 2024, members of the Oncology Data Advisor Editorial Board and Fellows Forum sat down for a panel discussion about the rising incidence of cancer diagnoses, factors contributing to them, and how to counsel...
In honor of Gallbladder and Bile Duct Cancer Awareness Month this February, Fellows Forum members Dr. Waqas Haque and Dr. Matthew Hadfield sat down for a discussion on the challenges in diagnosis of gallbladder and bile duct cancers and the importanc...
In honor of World Cancer Day on February 4, members of the Oncology Data Advisor Fellows Forum and Editorial Board joined forces for a thought-provoking discussion about improving cancer care on a global scale, including treatment access, molecular t...
Oncology Data Advisor® · National Cancer Prevention Month: Rising Trends and How to Combat Them In honor of National Cancer Prevention Month 2024, members of the Oncology Data Advisor Editorial Board and Fellows Forum sat down for a panel ...
Oncology Data Advisor® · Gallbladder and Bile Duct Cancer Awareness Month: Improving Screening and Treatment Options In honor of Gallbladder and Bile Duct Cancer Awareness Month this February, Fellows Forum members Dr. Waqas Haque and Dr. ...
Oncology Data Advisor® · Pancreatic Cancer Awareness Month: Improving Early Detection With Joseph Kalis, PharmD, BCOP This November, Oncology Data Advisor is honoring Pancreatic Cancer Awareness Month and helping to raise awareness about e...
By Waqas Haque, MD, MPH In this latest edition of The Way Ahead: The Convergence of Technology and Cancer Care, Dr. Waqas Haque shares his perspectives on a deep learning model for gallbladder cancer detection, a precision medicine platform for pancr...
The FDA has approved pembrolizumab (Keytruda®, Merck) with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor 2 (HER2)–negative ...
The FDA has amended the existing indication of pembrolizumab (Keytruda®, Merck) with trastuzumab, fluoropyrimidine, and platinum-containing chemotherapy for the first-line treatment of patients with locally advanced unresectable or metastatic human e...